Carmel Kealey
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Rheumatology top 5%
- Folate and B Vitamins Research
- Systemic Lupus Erythematosus Research
Papers in
-
- Folate and B Vitamins Research 4
- Surgery 4
- Esophageal and GI Pathology 2
- Co-authors
- Alexander S. Whitehead (8 shared papers)D. Brady (15 shared papers)Caroline F. Thorn (4 shared papers)Maureen Price (4 shared papers)Jason D. Christie (4 shared papers)Zhen Chen (4 shared papers)Stephen E. Kimmel (3 shared papers)Hedi Schelleman (2 shared papers)
- Journals
- Biotechnology Letters (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Microbial Pathogenesis (1 paper)Atherosclerosis (1 paper)Human Genetics (1 paper)
- Partner nations
- IrelandUnited StatesUnited Kingdom
In The Last Decade
Carmel Kealey
29 papers receiving 702 citations
Peers
Comparison fields: 5 of 110
- Pharmacology 248
- Rheumatology 146
- Biochemistry 47
- Endocrinology, Diabetes and Metabolism 95
- Endocrinology 31
Countries citing papers authored by Carmel Kealey
This map shows the geographic impact of Carmel Kealey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmel Kealey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmel Kealey more than expected).
Fields of papers citing papers by Carmel Kealey
This network shows the impact of papers produced by Carmel Kealey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmel Kealey. The network helps show where Carmel Kealey may publish in the future.
Co-authors
The 25 scholars most cited alongside Carmel Kealey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 95 | |
| 2 | 2006 | 89 | |
| 3 | 2007 | 88 | |
| 4 | 2007 | 73 | |
| 5 | 2017 | 50 | |
| 6 | 2007 | 45 | |
| 7 | 2005 | 42 | |
| 8 | 2009 | 40 | |
| 9 | 2000 | 32 | |
| 10 | 2017 | 27 | |
| 11 | 2022 | 25 | |
| 12 | 2008 | 18 | |
| 13 | 2005 | 17 | |
| 14 | 2018 | 14 | |
| 15 | 2000 | 12 | |
| 16 | 2018 | 9 | |
| 17 | 2001 | 8 | |
| 18 | 2021 | 5 | |
| 19 | 2006 | 5 | |
| 20 | 2024 | 5 |
About Carmel Kealey
Carmel Kealey is a scholar working on Rheumatology, Surgery, Pharmacology, Genetics and Endocrinology, having authored 29 papers that have together received 717 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Folate and B Vitamins Research (4 papers), Enterobacteriaceae and Cronobacter Research (4 papers), Genetic Associations and Epidemiology (3 papers), Hormonal Regulation and Hypertension (2 papers), Iron Metabolism and Disorders (2 papers), Esophageal and GI Pathology (2 papers) and Nanoparticles: synthesis and applications (2 papers). The work is most often cited by research in Pharmacology (248 citations), Rheumatology (146 citations), Biochemistry (47 citations), Endocrinology, Diabetes and Metabolism (95 citations) and Endocrinology (31 citations). Carmel Kealey has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Alexander S. Whitehead, D. Brady, Caroline F. Thorn, Maureen Price, Jason D. Christie, Zhen Chen, Stephen E. Kimmel, Hedi Schelleman, Craig Newcomb and Cormac D. Murphy. Their work appears in journals such as Biotechnology Letters, Clinical Pharmacology & Therapeutics, Microbial Pathogenesis, Atherosclerosis and Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.